Juq-934 Site

| Parameter | Mouse (IV) | Mouse (PO) | Rat (PO) | Human (predicted) | |-----------|------------|------------|----------|-------------------| | | 12 mL min⁻¹ kg⁻¹ | 8 mL min⁻¹ kg⁻¹ | 6 mL min⁻¹ kg⁻¹ | 4 mL min⁻¹ kg⁻¹ | | Volume of distribution (Vd) | 1.4 L kg⁻¹ | 1.9 L kg⁻¹ | 2.1 L kg⁻¹ | 2.5 L kg⁻¹ | | Half‑life (t½) | 1.2 h | 3.9 h | 5.3 h | 9–12 h | | Cmax (µM) at 30 mg kg⁻¹ PO | – | 2.6 | 2.3 | ~1.5 (projected) | | Oral bioavailability (F) | – | 58 % | 63 % | ~55 % (predicted) | | Plasma protein binding | 96 % (mouse) | 96 % (human) (by equilibrium dialysis) | | Metabolism | Primarily CYP3A4 (oxidative N‑dealkylation) | Minor glucuronidation (UGT1A9) | – | – | | Excretion | 70 % fecal (as metabolites), 20 % urinary | – | – | – |

The product code serves as the unique identifier for this specific work. This code is essential for viewers, collectors, and critics to accurately reference the title, especially given the vast number of releases from Madonna and other studios. The JUQ prefix is exclusive to Madonna, and the numbers indicate its chronological order within the series. JUQ-934 was officially released on October 8, 2024 , positioning it as a recent and relevant addition to the studio’s lineup for the latter half of the year. JUQ-934

Before diving deeper, let's start with the essential facts that define this release. | Parameter | Mouse (IV) | Mouse (PO)